Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,418 public trials 2,849 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Terminated

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

NCT04628871

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Carbohydrate Metabolism, Inborn Errors, +24 more
Locations
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • New York University Grossman School of Medicine New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Terminated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

NCT01437787

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic Neoplasm, +3 more
Locations
  • Investigational Site Number 840014 Scottsdale, Arizona, United States
  • Investigational Site Number 840001 La Jolla, California, United States
  • Investigational Site Number 840012 La Jolla, California, United States
  • Investigational Site Number 840006 Los Angeles, California, United States
View all 101 locations
View Trial Details
Terminated

BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma

NCT05376345

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Beijing Boren Hospital Beijing, Beijing Municipality, China
  • Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China
  • Shanghai Changzheng Hospital Shanghai, China
  • Shanghai Fourth People's Hospital Affiliated to Tongji University Shanghai, China
View Trial Details
Terminated

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

NCT04438382

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +5 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Bronson Battle Creek Battle Creek, Michigan, United States
  • Mercy Health Saint Mary's Grand Rapids, Michigan, United States
View all 18 locations
View Trial Details
Terminated

Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia

NCT02075463

Conditions
Anaemia, Anemia, Chronic Disease, +13 more
Locations
  • GSK Investigational Site Azusa, California, United States
  • GSK Investigational Site Glendale, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Simi Valley, California, United States
View Trial Details

Related conditions